Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02357667 · ClinicalTrials.gov registry record
The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 192
- Enrollment target
NCT02357667: Completed study, sponsored by University of Pennsylvania.
NCT02357667 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 192 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02357667 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 192 participants
- Enrollment target
Study Summary
This study will evaluate the differences in cardiovascular parameters between women with severe preterm preeclampsia and those without preeclampsia using echocardiography and maternal blood. The investigators will also look at associations of abnormal cardiovascular findings and immediate complications among a high risk cohort of pregnant African American women.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-04-20 |
What the finished NCT02357667 record still lists
NCT02357667 is an observational study that tracks outcomes without assigning an intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02357667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02357667 about?
NCT02357667 is a clinical study titled "The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study". This study will evaluate the differences in cardiovascular parameters between women with severe preterm preeclampsia and those without preeclampsia using echocardiography and maternal blood. The investigators will also look at associations of abnormal cardiovascular findings and immediate complicati...
What is the current status of trial NCT02357667?
This trial is currently completed. The enrollment target is 192 participants. The study started on 2015-03. Estimated completion is 2017-04-20.
Who is sponsoring clinical trial NCT02357667?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia